Ovid Financial Statements From 2010 to 2026

Ovid Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 100.8 M 106 M 72.6 M Slightly volatile Other Current Liabilities 6 M 6.9 M 4.3 M Slightly volatile Total Current Liabilities 9.7 M 12.1 M 7 M Slightly volatile Total Stockholder Equity 82.6 M 78.5 M 59.2 M Slightly volatile Net Tangible Assets 81.7 M 152.1 M 69.8 M Slightly volatile Property Plant And Equipment Net 16 M 15.2 M 4.5 M Slightly volatile Accounts Payable 3.2 M 3.7 M 2.3 M Slightly volatile Cash 28.7 M 30.2 M 42.9 M Slightly volatile Non Current Assets Total 43.7 M 41.7 M 11.2 M Slightly volatile Non Currrent Assets Other 1.1 M 2.2 M 856.1 K Slightly volatile Cash And Short Term Investments 88 M 61 M 61.7 M Slightly volatile Common Stock Shares Outstanding 46.6 M 81.5 M 36 M Slightly volatile Liabilities And Stockholders Equity 100.8 M 106 M 72.6 M Slightly volatile Other Current Assets 2.1 M 3.3 M 1.6 M Slightly volatile Other Stockholder Equity 261.5 M 428.4 M 195.6 M Slightly volatile Total Liabilities 18.2 M 27.5 M 13.4 M Slightly volatile Total Current Assets 90.2 M 64.3 M 63.3 M Slightly volatile Intangible Assets 211.2 K 105.8 K 143.5 K Slightly volatile Common Stock 51.3 K 81.7 K 42.7 K Slightly volatile Property Plant Equipment 1.4 M 1.3 M 399.9 K Slightly volatile Net Receivables 403.4 K 300.4 K 269.5 K Slightly volatile Common Stock Total Equity 46.7 K 81 K 38.7 K Slightly volatile Property Plant And Equipment Gross 17.7 M 16.8 M 4.9 M Slightly volatile Capital Surpluse 312.6 M 411.4 M 260.8 M Slightly volatile Net Invested Capital 96.8 M 78.5 M 86.1 M Pretty Stable Net Working Capital 94 M 52.2 M 82.8 M Very volatile Capital Stock 67.2 K 81.7 K 45.5 K Slightly volatile Other Liabilities 12.4 M 11.8 M 4.6 M Slightly volatile Non Current Liabilities Other 36.2 M 34.5 M 11.4 M Slightly volatile Current Deferred Revenue 1.8 M 2 M 2.2 M Slightly volatile Short and Long Term Debt Total 12.6 M 13.3 M 16 M Slightly volatile Short Term Debt 1.1 M 1.5 M 717.8 K Slightly volatile
Ovid Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 365.4 K 705 K 278.5 K Slightly volatile Selling General Administrative 22.9 M 29.5 M 16.6 M Slightly volatile Other Operating Expenses 57.3 M 71.8 M 41.4 M Slightly volatile Research Development 34.3 M 42.3 M 24.7 M Slightly volatile Total Operating Expenses 57.3 M 71.8 M 41.4 M Slightly volatile Interest Income 4.7 M 4.5 M 2.1 M Slightly volatile Net Interest Income 4.7 M 4.5 M 2.1 M Slightly volatile Reconciled Depreciation 639.5 K 705 K 385.7 K Slightly volatile Non Operating Income Net Other 957.3 K 1.6 M 761.8 K Slightly volatile Selling And Marketing Expenses 581 653 713 Slightly volatile
Ovid Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Sale Purchase Of Stock 154.5 K 162.6 K 19 M Pretty Stable Net Borrowings 64 K 72 K 78.6 K Slightly volatile Stock Based Compensation 5.6 M 7.2 M 4.1 M Slightly volatile Depreciation 468.3 K 705 K 345 K Slightly volatile Capital Expenditures 77.6 K 81.7 K 191.7 K Slightly volatile End Period Cash Flow 30.8 M 32.5 M 43.9 M Slightly volatile Change To Netincome 8.9 M 7.5 M 6 M Slightly volatile Begin Period Cash Flow 31.7 M 33.3 M 42.3 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 127 105 66.7784 Slightly volatile PTB Ratio 1.06 1.12 5.1187 Slightly volatile Days Sales Outstanding 3.28 3.69 4.0285 Slightly volatile Book Value Per Share 2.21 1.11 1.733 Very volatile Average Payables 2.1 M 3.2 M 2.4 M Slightly volatile Stock Based Compensation To Revenue 6.93 9.98 3.6394 Slightly volatile Capex To Depreciation 0.13 0.1158 1.1498 Slightly volatile PB Ratio 1.06 1.12 5.1187 Slightly volatile EV To Sales 115 86.91 57.2891 Slightly volatile Payables Turnover 0.0253 0.034 0.0299 Slightly volatile Sales General And Administrative To Revenue 23.21 40.84 13.7273 Slightly volatile Average Inventory 97.1 K 109.2 K 119.2 K Slightly volatile Research And Ddevelopement To Revenue 61.39 58.46 19.4261 Slightly volatile Capex To Revenue 0.11 0.1254 0.1166 Slightly volatile Cash Per Share 0.82 0.86 1.7199 Very volatile Days Payables Outstanding 14.5 K 11.1 K 13.9 K Slightly volatile Income Quality 2.0 1.91 0.9346 Slightly volatile Intangibles To Total Assets 0.0011 0.0011 0.0018 Pretty Stable Current Ratio 5.81 6.11 19.7462 Slightly volatile Tangible Book Value Per Share 1.05 1.11 1.6613 Very volatile Receivables Turnover 71.2 80.1 87.4314 Slightly volatile Shareholders Equity Per Share 2.21 1.11 1.733 Very volatile Debt To Equity 0.14 0.19 0.1385 Slightly volatile Capex Per Share 9.0E-4 9.0E-4 0.0042 Pretty Stable Graham Net Net 0.45 0.47 1.4644 Pretty Stable Average Receivables 60.6 K 63.8 K 138 K Pretty Stable Revenue Per Share 0.0087 0.0092 0.3244 Very volatile Interest Debt Per Share 0.24 0.2081 0.2334 Pretty Stable Debt To Assets 0.1 0.14 0.1115 Slightly volatile Graham Number 8.36 9.4 10.261 Slightly volatile Operating Cycle 3.28 3.69 4.0285 Slightly volatile Price Book Value Ratio 1.06 1.12 5.1187 Slightly volatile Days Of Payables Outstanding 14.5 K 11.1 K 13.9 K Slightly volatile Ebt Per Ebit 0.47 0.49 0.8932 Slightly volatile Effective Tax Rate 0.0101 0.0096 0.0057 Slightly volatile Company Equity Multiplier 0.98 1.22 1.1693 Slightly volatile Total Debt To Capitalization 0.12 0.16 0.121 Slightly volatile Debt Equity Ratio 0.14 0.19 0.1385 Slightly volatile Quick Ratio 5.81 6.11 19.7424 Slightly volatile Net Income Per E B T 0.79 0.89 0.9717 Slightly volatile Cash Ratio 2.73 2.87 17.7437 Slightly volatile Days Of Sales Outstanding 3.28 3.69 4.0285 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.11 1.15 1.0215 Slightly volatile Price To Book Ratio 1.06 1.12 5.1187 Slightly volatile Fixed Asset Turnover 0.0467 0.0492 111 Very volatile Debt Ratio 0.1 0.14 0.1115 Slightly volatile Price Sales Ratio 127 105 66.7784 Slightly volatile Asset Turnover 0.0067 0.0071 0.1724 Pretty Stable Price Fair Value 1.06 1.12 5.1187 Slightly volatile
Ovid Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 141.4 M 76.1 M 129.9 M Slightly volatile Enterprise Value 87.2 M 62.9 M 80.2 M Slightly volatile

Ovid Fundamental Market Drivers

Ovid Upcoming Events

About Ovid Therapeutics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ovid Therapeutics is a strong investment it is important to analyze Ovid Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ovid Therapeutics' future performance. For an informed investment choice regarding Ovid Stock, refer to the following important reports:

How To Invest In Ovid Details

Is Ovid Stock a good investment? Details

What is Ovid Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details